Barclays PLC
NYSE:BCSBanks - Diversified
+$0.12 today
- Market cap
- $72.23B
- Beta
- 0.90
- P/E (TTM)
- 9.5
- EPS (TTM)
- $0.53
- Dividend yield
- 1.72%
Volume 4.84M
Average 6.73M
BCS Cost of Revenue
Direct costs of producing the goods and services sold, such as materials, manufacturing, and service delivery.
Barclays PLCNYSE: BCS
Cost of Revenue · Q3 FY2026 · quarter ended Sep 2026
Cost of revenue declines year over year
Q3 FY2026 cost of revenue of £499.04M fell 21.2% year over year, behind the -0.0% change in trailing-twelve-month cost of revenue. Sequentially, it fell 13.3% from the prior quarter. Over 3 fiscal years it compounded at +30.6% a year.
Context
- Cost of revenue amounted to 42.7% of revenue in FY2025, down 6.4 pp from a year earlier.
- Cost of revenue increased in 2 of the last 3 fiscal years.
What to watch
Whether quarterly growth recovers from -21.2% toward the trailing-twelve-month pace of -0.0%.
Sources:Income StatementText generated from reported figures; not investment advice.
Cost of Revenue history
GBP · from the income statement
- Latest · FY2025
- 21.69B GBP
- Year-over-year change
- -22.4%
- 4-year CAGR
- +61.8%
| Period | Period end | Cost of Revenue | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 21.69B | -22.4% |
| FY2024 | 2024-12-31 | 27.96B | +16.9% |
| FY2023 | 2023-12-31 | 23.91B | +145.3% |
| FY2022 | 2022-12-31 | 9.75B | +207.8% |
| FY2021 | 2021-12-31 | 3.17B | — |
Cost of Revenue vs competitors
How BCS compares with its peers on the latest reported figures
- Peers report in different currencies, so cost of revenue is compared through growth and share of revenue rather than absolute size.
- Its year-over-year change of -0.0% is the 4th highest of 9, against a peer median of -7.7%.
- Cost of revenue amounts to 7.9% of revenue for BCS, versus a peer median of 45.5%.
| Company | Period | LTM | YoY | 3-year CAGR | % of revenue |
|---|---|---|---|---|---|
| LTM Sep 2026 | $111.19B USD | +0.6% | +51.2% | 36.8% | |
| LTM Sep 2026 | $77.05B USD | -11.8% | +54.9% | 39.6% | |
| LTM Jul 2026 | CA$73.53B CAD | -3.5% | +59.5% | 51.5% | |
| LTM Sep 2026 | $71.39B USD | -24.0% | +44.6% | 46.3% | |
| LTM Jun 2026 | $60.72B USD | -12.8% | +41.1% | 45.1% | |
| LTM Jul 2026 | CA$51.53B CAD | -17.1% | +58.8% | 45.8% | |
| LTM Jun 2026 | €43.09B EUR | +53.0% | +18.1% | 47.8% | |
| LTM Jun 2026 | €14.93B EUR | +6.7% | -27.1% | 30.6% | |
| LTM Sep 2026 | £2.44B GBP | -0.0% | +30.6% | 7.9% | |
| Peer median (excluding BCS) | — | -7.7% | +47.9% | 45.5% | |
Competitors are the stored peer set for BCS. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Income Statement
Metric | FY2021 Dec 2021 | FY2022 Dec 2022 | FY2023 Dec 2023 | FY2024 Dec 2024 | FY2025 Dec 2025 |
|---|---|---|---|---|---|
| Revenue | 25.12B | 33.3B | 49.77B | 57.02B | 50.83B |
| Cost of Revenue | 3.17B | 9.75B | 23.91B | 27.96B | 21.69B |
| Gross Profit | 21.95B | 23.55B | 25.86B | 29.05B | 29.14B |
| Gross Margin | 87.4% | 70.7% | 52.0% | 51.0% | 57.3% |
| Research & Development | 0 | 0 | 0 | 0 | 0 |
| Selling, General & Admin | 1.97B | 10.95B | 11.77B | 11.94B | 2.73B |
| Operating Expenses | 13.76B | 16.52B | 19.4B | 20.81B | 20B |
| Depreciation & Amortization | 1.67B | 1.72B | 1.78B | 1.7B | 1.76B |
| EBITDA | 9.87B | 8.76B | 8.24B | 9.94B | 10.9B |
| EBITDA Margin | 39.3% | 26.3% | 16.6% | 17.4% | 21.4% |
| Operating Income | 8.19B | 7.04B | 6.45B | 8.28B | 9.14B |
| Operating Margin | 32.6% | 21.1% | 13.0% | 14.5% | 18.0% |
| Interest Income | 11.24B | 19.21B | 34.5B | 39.14B | 36.19B |
| Interest Expense | 3.17B | 8.56B | 22B | 25.93B | 21.69B |
| Other Income / Expenses | 0 | (6.03M) | 8.85M | (37.78M) | 0 |
| Income Before Tax | 8.19B | 7.04B | 6.46B | 8.24B | 9.14B |
| Pre-Tax Margin | 32.6% | 21.1% | 13.0% | 14.5% | 18.0% |
| Income Tax Expense | 1.14B | 1.04B | 1.21B | 1.79B | 1.93B |
| Net Income | 7.01B | 5.95B | 5.17B | 6.44B | 7.17B |
| Net Margin | 27.9% | 17.9% | 10.4% | 11.3% | 14.1% |
| EPS (Basic) | 1.48 | 1.24 | 1.12 | 1.44 | 1.80 |
| EPS (Diluted) | 1.44 | 1.20 | 1.08 | 1.40 | 1.80 |
| Weighted Avg Shares | 4.25B | 4.08B | 3.86B | 3.69B | 3.45B |
| Weighted Avg Shares (Diluted) | 4.36B | 4.22B | 3.97B | 3.82B | 3.45B |
Barclays PLC
NYSE:BCS
Intrinsic Alpha fair value
Locked
Current Price
$21.60
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.